AMGN Imdelltra plus Imfinzi shows improved overall survival
TradeXchange Newsdesk says AMGN’s Imdelltra in combination with Imfinzi demonstrated landmark improvement in overall survival in first-line extensive-stage small cell lung cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.